BetterLife Pharma (BETRF) Short Interest Ratio & Short Volume $0.07 +0.00 (+1.43%) As of 05/2/2025 10:51 AM Eastern Add Compare Share Share Short Interest Stock AnalysisChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock BetterLife Pharma Short Interest DataBetterLife Pharma (BETRF) has a short interest of 9,600 shares, representing 0.01% of the float (the number of shares available for trading by the public). This marks a 0.00% change in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 16,559 shares to cover all short positions.Current Short Interest9,600 sharesPrevious Short Interest9,600 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$504.96Short Interest Ratio0.6 Days to CoverLast Record DateApril 15, 2025Outstanding Shares129,463,000 sharesShort Percent of Float0.01%Today's Trading Volume10,000 sharesAverage Trading Volume16,559 sharesToday's Volume Vs. Average60% Short Selling BetterLife Pharma? Sign up to receive the latest short interest report for BetterLife Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBETRF Short Interest Over TimeBETRF Days to Cover Over TimeBETRF Percentage of Float Shorted Over Time BetterLife Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20259,600 shares $504.96 No Change0.0%0.6 $0.05 3/31/20259,600 shares $632.64 -33.8%0.0%0.8 $0.07 3/15/202514,500 shares $1,031.53 -41.5%0.0%0.9 $0.07 2/28/202524,800 shares $2,073.28 -3.1%0.0%2 $0.08 2/15/202525,600 shares $2,219.52 -0.8%0.0%0.7 $0.09 1/31/202525,800 shares $2,291.04 No ChangeN/A0.4 $0.09 1/15/20252,800 shares $207.48 No ChangeN/A0 $0.07 12/31/20242,800 shares $201.60 No ChangeN/A0 $0.07 11/30/202413,800 shares $1,255.80 +89.0%N/A0.5 $0.09 11/15/20247,300 shares $520.49 -67.1%N/A0.3 $0.07 Get the Latest News and Ratings for BETRF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BetterLife Pharma and its competitors with MarketBeat's FREE daily newsletter. 10/31/202422,200 shares $1,636.14 +22,100.0%N/A0.3 $0.07 10/15/2024100 shares $8.55 -80.0%N/A0 $0.09 9/30/2024500 shares $47.50 No ChangeN/A0 $0.10 8/31/2024800 shares $82.08 -38.5%N/A0 $0.10 8/15/20241,300 shares $117.00 -77.2%N/A0.1 $0.09 7/31/20245,700 shares $627.00 -61.0%N/A0.1 $0.11 7/15/202414,600 shares $1,512.56 +47.5%N/A0.3 $0.10 6/30/20249,900 shares $792.00 -54.2%N/A0.4 $0.08 6/15/202421,600 shares $1,918.94 -63.4%N/A0.3 $0.09 5/31/202459,000 shares $4,985.50 +52.9%N/A3.8 $0.08 5/15/202438,600 shares $3,531.90 +1,508.3%N/A0.4 $0.09 4/30/20242,400 shares $198.96 -83.8%N/A0.1 $0.08 4/15/202414,800 shares $1,095.20 +516.7%N/A0.3 $0.07 3/31/20242,400 shares $168.00 No ChangeN/A0.1 $0.07 3/15/20242,400 shares $173.28 No ChangeN/A0 $0.07 2/29/20242,400 shares $148.80 -92.8%N/A0.1 $0.06 2/15/202433,200 shares $2,075.00 +0.3%N/A0.3 $0.06 1/15/202414,900 shares $1,072.80 +520.8%N/A0.1 $0.07 12/31/20232,400 shares $115.10 -67.1%N/A0 $0.05 12/15/20237,300 shares $334.34 +204.2%N/A0.4 $0.05 11/30/20232,400 shares $109.92 No ChangeN/A0.1 $0.05 11/15/20232,400 shares $106.80 No ChangeN/A0.3 $0.04 10/31/20232,400 shares $110.35 No ChangeN/A0 $0.05 10/15/20232,400 shares $119.52 -7.7%N/A0 $0.05 9/30/20232,600 shares $134.58 +8.3%N/A0.1 $0.05 9/15/20232,400 shares $141.84 No ChangeN/A0.1 $0.06 8/31/20232,400 shares $155.52 No ChangeN/A0 $0.06 8/15/20232,400 shares $121.44 No ChangeN/A0 $0.05 7/31/20232,400 shares $125.76 -55.6%N/A0.1 $0.05 7/15/20235,400 shares $297.00 -81.6%N/A0.1 $0.06Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 6/30/202329,300 shares $1,611.50 +21.6%N/A0.6 $0.06 6/15/202324,100 shares $1,337.55 -49.2%N/A0.5 $0.06 5/31/202347,400 shares $2,820.30 No ChangeN/A1.4 $0.06 5/15/202347,400 shares $2,554.86 No ChangeN/A2 $0.05 4/30/202347,400 shares $2,938.80 No ChangeN/A4.1 $0.06 4/15/202347,400 shares $2,802.29 +867.4%N/A0.3 $0.06 3/31/20234,900 shares $298.90 -90.1%N/A0.1 $0.06 3/15/202349,300 shares $3,278.45 -43.5%N/A0.5 $0.07 2/28/202387,300 shares $7,804.62 No ChangeN/A1 $0.09 2/15/202387,300 shares $8,345.88 -32.9%N/A3.8 $0.10 1/31/2023130,100 shares $14,454.11 +4,718.5%N/A1.5 $0.11 1/15/20232,700 shares $337.50 No ChangeN/A0.2 $0.13 12/30/20222,700 shares $328.32 No ChangeN/A0 $0.12 12/15/20222,700 shares $351.00 -3.6%N/A0 $0.13 11/30/20222,800 shares $331.80 -91.6%N/A0.2 $0.12 11/15/202233,300 shares $4,085.91 +23.8%N/A0.6 $0.12 10/31/202226,900 shares $3,362.50 -24.7%N/A0.4 $0.13 10/15/202235,700 shares $4,873.05 -38.1%N/A1.2 $0.14 9/30/202257,700 shares $8,193.40 +12.0%N/A1.1 $0.14 9/15/202251,500 shares $7,915.55 -5.5%N/A0.8 $0.15 8/31/202254,500 shares $7,630.00 -3.9%N/A0.7 $0.14 8/15/202256,700 shares $9,072.00 No ChangeN/A0.6 $0.16 7/31/202256,700 shares $6,237.00 -0.7%N/A3.4 $0.11 7/15/202257,100 shares $5,550.12 -20.5%N/A1.2 $0.10 6/30/202271,800 shares $5,241.40 -6.6%N/A2.5 $0.07 6/15/202276,900 shares $5,383.00 -8.5%N/A1.8 $0.07 5/31/202284,000 shares $7,140.00 +0.2%N/A5.4 $0.09 5/15/202283,800 shares $8,840.90 +13.9%N/A1 $0.11 4/30/202273,600 shares $7,985.60 +63.2%N/A1.2 $0.11 4/15/202245,100 shares $4,735.50 -23.3%N/A0.7 $0.11 3/31/202258,800 shares $7,302.96 +27.0%N/A0.7 $0.12 3/15/202246,300 shares $5,486.55 +4.5%N/A0.6 $0.12 2/28/202244,300 shares $6,290.60 -14.3%N/A0.4 $0.14 2/15/202251,700 shares $8,163.43 +17.2%N/A0.4 $0.16 1/31/202244,100 shares $7,056.00 -54.8%N/A0.1 $0.16 1/15/202297,500 shares $18,183.75 -18.2%N/A0.3 $0.19 12/31/2021119,200 shares $20,275.92 +59,500.0%N/A0.6 $0.17 12/15/2021200 shares $32.52 -99.6%N/A0 $0.16 11/30/202156,200 shares $11,802.00 +56,100.0%N/A0.2 $0.21 11/15/2021100 shares $21.52 -98.9%N/A0 $0.22 10/29/20218,700 shares $1,986.21 -30.4%N/A0.1 $0.23 10/15/202112,500 shares $3,028.75 +237.8%N/A0.1 $0.24 9/30/20213,700 shares $815.11 -65.1%N/A0 $0.22 9/15/202110,600 shares $2,556.72 +79.7%N/A0.2 $0.24 8/31/20215,900 shares $1,260.24 -59.6%N/A0.1 $0.21 8/13/202114,600 shares $3,210.54 -5.2%N/A0.2 $0.22 7/30/202115,400 shares $3,828.44 +11.6%N/A0.1 $0.25 7/15/202113,800 shares $3,191.94 -30.3%N/A0.1 $0.23 6/30/202119,800 shares $4,478.76 +75.2%N/A0.1 $0.23 6/15/202111,300 shares $3,151.57 -9.6%N/A0 $0.28Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.Click here to access the full report now. 5/28/202112,800 shares $4,203.52 +412.0%N/A0.1 $0.33 5/14/20212,500 shares $1,126.25 +1,150.0%N/A0 $0.45 4/30/2021200 shares $106.64 -75.0%N/A0 $0.53 4/15/2021800 shares $532.48 -94.8%N/A0 $0.67 3/31/202115,500 shares $14,415.00 +3,000.0%N/A0.2 $0.93 3/15/2021500 shares $579.75 -61.5%N/A0 $1.16 2/26/20211,300 shares $1,482.00 -83.5%N/A0 $1.14 2/12/20217,900 shares $9,076.31 +172.4%N/A0.1 $1.15 1/29/20212,900 shares $3,306.00 -69.2%N/A0 $1.14 1/15/202113,800 shares $17,664.00 +961.5%N/A0.4 $1.28 12/31/20207,900 shares $13,588.00 -42.8%N/A0 $1.72 12/15/202013,800 shares $11,730.00 +961.5%N/A0.4 $0.85 11/30/20201,300 shares $547.25 +62.5%N/A0 $0.42 11/15/2020800 shares $373.44 -38.5%N/A0 $0.47 10/30/20201,300 shares $650.00 +30.0%N/A0.1 $0.50 10/15/20201,000 shares $797.00 -81.1%N/A0 $0.80 9/30/20205,300 shares $4,165.80 +12.8%N/A0.4 $0.79 9/15/20204,700 shares $4,607.41 -25.4%N/A0.3 $0.98 BETRF Short Interest - Frequently Asked Questions What is BetterLife Pharma's current short interest? Short interest is the volume of BetterLife Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 9,600 shares of BETRF short. 0.01% of BetterLife Pharma's shares are currently sold short. Learn More on BetterLife Pharma's current short interest. What is a good short interest ratio for BetterLife Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BETRF shares currently have a short interest ratio of 1.0. Learn More on BetterLife Pharma's short interest ratio. What is a good short interest percentage for BetterLife Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.01% of BetterLife Pharma's floating shares are currently sold short. How does BetterLife Pharma's short interest compare to its competitors? 0.01% of BetterLife Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BetterLife Pharma: Aligos Therapeutics, Inc. (20.70%), NRx Pharmaceuticals, Inc. (8.84%), Kezar Life Sciences, Inc. (1.09%), Estrella Immunopharma, Inc. (0.02%), Barinthus Biotherapeutics plc (0.05%), Surrozen, Inc. (4.90%), FibroGen, Inc. (4.23%), AlloVir, Inc. (2.56%), Cadrenal Therapeutics, Inc. (2.45%), X4 Pharmaceuticals, Inc. (5.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short BetterLife Pharma stock? Short selling BETRF is an investing strategy that aims to generate trading profit from BetterLife Pharma as its price is falling. BETRF shares are trading up $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BetterLife Pharma? A short squeeze for BetterLife Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BETRF, which in turn drives the price of the stock up even further. How often is BetterLife Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BETRF, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ALGS Short Squeeze NRXP Short Squeeze KZR Short Squeeze ESLA Short Squeeze BRNS Short Squeeze SRZN Short Squeeze FGEN Short Squeeze ALVR Short Squeeze CVKD Short Squeeze XFOR Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BETRF) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BetterLife Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BETRF Stock Free BETRF Stock Alerts